NCT03159884
The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV) treatment 4 unknown_status NCT01360151
Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy diagnostic Not Available unknown_status NCT04714242
OCTA and Polypoidal Choroidal Vasculopathy Not Available Not Available completed NCT01950741
Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy treatment 4 completed NCT01248117
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy treatment 1 / 2 unknown_status NCT03117634
An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy treatment 4 completed NCT03128463
Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases Not Available Not Available unknown_status NCT02381730
Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment treatment Not Available completed NCT00837330
Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy treatment 1 / 2 completed NCT01271426
Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs No drug interventions Not Available Not Available completed NCT04380974
Efficacy and Safety of Two Regimens of Anti-VEGF Therapy in Chinese Patients With Polypoidal Choroidal Vasculopathy No drug interventions treatment 4 unknown_status NCT02821520
Initial Versus Delayed PDT Combination With Conbercept in PCV treatment 4 completed NCT03929731
Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV) No drug interventions Not Available Not Available recruiting NCT04707027
Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept treatment Not Available unknown_status NCT02815176
Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers No drug interventions Not Available Not Available unknown_status NCT05639660
Clinical Implication of Aflibercept in PCV Treatment in China No drug interventions Not Available Not Available recruiting NCT03459144
Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen treatment Not Available completed NCT00383812
Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy treatment Not Available unknown_status NCT00424710
Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) treatment 1 completed NCT02141308
OCT in Rare Chorioretinal Diseases No drug interventions Not Available Not Available recruiting NCT05662943
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV Not Available Not Available completed NCT03941587
Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment treatment Not Available active_not_recruiting NCT00470977
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy treatment 1 / 2 completed NCT01884597
Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2) treatment 1 / 2 completed NCT01469156
Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy treatment 1 / 2 completed NCT05229237
Conbercept for Polypoidal Choroidal Vasculopathy（START Study） Not Available Not Available completed NCT00344617
Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy treatment 3 unknown_status NCT01846273
Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) treatment 4 completed NCT01871376
Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation treatment 4 completed NCT02976194
Intraocular Cytokine in Recurrence of Polypoidal Choroidal Vasculopathy basic_science 4 unknown_status NCT04101604
Biomarkers of Common Eye Diseases No drug interventions Not Available Not Available unknown_status NCT02769169
Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy treatment 2 / 3 terminated NCT02495181
Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy treatment 4 completed NCT01023295
Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV) treatment 2 completed NCT02597855
Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy Not Available Not Available unknown_status NCT00674323
Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy treatment 4 completed NCT03244657
Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy treatment 4 unknown_status